CCS News

TAVI has rapidly changed the treatment of patients with severe symptomatic aortic stenosis

The 2019 CCS Position Statement for Transcatheter Aortic Valve Implantation incorporates clinical evidence to provide a practical framework for patient selection that relies on individual patient evaluation of risk and benefit from either TAVI or surgical aortic valve replacement.

Check out the full publication in the Canadian Journal of Cardiology (CJC).

New report shows access to and wait times for life-saving cardiac procedure depends on where you live, highlights need for new approaches to ensure pan-Canadian equity

In the last decade, transcatheter aortic valve implantation (TAVI) – an innovative, non-invasive surgical procedure – has become the preferred treatment option for many heart patients. Yet the latest pan-Canadian data on TAVI care shows that access is highly variable across Canada and that healthcare resources are not keeping pace with the growing healthcare need.

Read our full press release 

The Canadian Cardiovascular Society announces recipients of the Early Career Atrial Fibrillation and Arrhythmia Award.

The Canadian Cardiovascular Society (CCS) is pleased to recognize seven outstanding Canadian researchers whose five projects have been selected to receive funding as part of the Early Career Atrial and Arrythmia (ECA3) Research Award.

Read our full press release

Finalists for the CCS-Bayer Vascular Award to be chosen during Canadian Cardiovascular Congress

The Canadian Cardiovascular Society (CCS) has announced the three finalists in the CCS-Bayer Vascular Awards competition.

Read our full press release

Budget 2019 fails to include funding for the CCS Quality Project

Despite best efforts and major support at the highest level of government, federal Budget 2019 shows no sign of funds for the CCS Quality Project. Without this year’s federal funding commitment, the CCS will have no choice but to scale down the project, limiting our ability to advance quality cardiovascular care in Canada.

Read our full press release